Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with
Everything about lung cancer is here.
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with
Lung cancer is one of the most deadly diseases that affects both men and women all around the world. It
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab
Lung cancer is one of the deadliest forms of cancers prevalent globally. Immunotherapy has emerged as one of the most
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to